Zidovudine how supplied

Jump to navigation Jump to search
Zidovudine
RETROVIR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

How Supplied

RETROVIR Tablets 300 mg (biconvex, white, round, film-coated) containing 300 mg zidovudine, one side engraved “GX CW3” and “300” on the other side.

Bottle of 60 (NDC 49702-214-18).

Store at 15° to 25°C (59° to 77°F).

RETROVIR Capsules 100 mg (white, opaque cap and body) containing 100 mg zidovudine and printed with “Wellcome” and unicorn logo on cap and “Y9C” and “100” on body.

Bottles of 100 (NDC 49702-211-20).

Store at 15° to 25°C (59° to 77°F) and protect from moisture.

RETROVIR Syrup (colorless to pale yellow, strawberry-flavored) containing 10 mg zidovudine in each mL.

Bottle of 240 mL (NDC 49702-212-48) with child-resistant cap. Store at 15° to 25°C (59° to 77°F).[1]

References

  1. "RETROVIR (ZIDOVUDINE) CAPSULE RETROVIR (ZIDOVUDINE) TABLET, FILM COATED RETROVIR (ZIDOVUDINE) SYRUP [VIIV HEALTHCARE COMPANY]". Retrieved 9 January 2014.

Adapted from the FDA Package Insert.